*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Allarity Therapeutics, Inc. is a clinical-stage, precision medicine pharmaceutical company. It is advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its clinical program includes three anti-cancer assets in mid-stage clinical development and one anti-cancer asset in early-stage clinical development. Its programs and partnerships leverage its Drug Response Predictor technology to refine patient selection and improve clinical outcomes. It is focused on clinical development of three programs: dovitinib in combination with stenoparib for the second-line or later treatment of metastatic ovarian cancer; stenoparib as a monotherapy for ovarian cancer, and IXEMPRA as a monotherapy for metastatic breast cancer. Its dovitinib is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. Its IXEMPRA is a selective microtubule inhibitor, which has been shown to interfere with cancer cell division, to cell death.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
The current share price compared to the 52-week low.
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
May 30, 2023 | |
---|---|
6:00 am ET | |
Globe Newswire | |
April 27, 2023 | |
9:01 am ET | |
Accesswire | |
April 19, 2023 | |
9:17 am ET | |
Globe Newswire | |
April 17, 2023 | |
9:02 am ET | |
Accesswire | |
April 11, 2023 | |
7:00 am ET | |
Globe Newswire | |
March 28, 2023 | |
6:00 am ET | |
Globe Newswire | |
March 24, 2023 | |
6:00 am ET | |
Globe Newswire | |
March 20, 2023 | |
6:00 am ET | |
Globe Newswire | |
Go to all current & historical news |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.